Related Experiment Video
Updated: May 15, 2026

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
Published on: February 9, 2022
Spirometry and PRAM severity score changes during pediatric acute asthma exacerbation treatment in a pediatric
Donald H Arnold1, Tebeb Gebretsadik, Tina V Hartert
1Department of Pediatrics, Division of Emergency Medicine, Center for Asthma and Environmental Sciences Research, Vanderbilt University Medical Center, Nashville, TN 37232-9001, USA. don.arnold@vanderbilt.edu
Insights
Pediatric asthma exacerbations show most lung function improvement within the first two hours of treatment. The Pediatric Respiratory Assessment Measure (PRAM) effectively tracks clinical severity changes beyond this initial period, unlike spirometry.
Area of Science:
- Pediatric Emergency Medicine
- Respiratory Medicine
- Clinical Trials
Background:
- Acute asthma exacerbations are a common reason for pediatric emergency department visits.
- Monitoring treatment response in children with asthma requires sensitive and timely measures.
- Spirometry, specifically percent-predicted forced expiratory volume in 1 second (%FEV(1)), is a standard measure of lung function.
Purpose of the Study:
- To evaluate the time-dependent changes in %FEV(1) and the Pediatric Respiratory Assessment Measure (PRAM) during acute asthma exacerbation treatment.
- To compare the sensitivity of %FEV(1) and PRAM in detecting changes in asthma severity over time.
Main Methods:
- Prospective study of 503 pediatric patients (aged 5-17 years) with acute asthma exacerbations.
- %FEV(1) and PRAM scores were recorded at baseline, 2 hours, and 4 hours post-treatment initiation.
- Analysis focused on changes within the first (0-2 hours) and second (2-4 hours) 2-hour treatment intervals.
Main Results:
- Significant improvement in %FEV(1) was observed during the first 2 hours (+15.4%), but not during the subsequent 2 hours (+1.5%).
- The PRAM showed significant improvement during both the first (-2.1 points) and second (-1.0 point) 2-hour treatment periods.
- A total of 503 participants were included, with a median age of 8.8 years; 61% were male and 63% were African-American.
Conclusions:
- The majority of lung function improvement in pediatric asthma exacerbations occurs within the initial 2 hours of treatment.
- The PRAM demonstrates continued sensitivity to changes in clinical severity during the second 2-hour treatment period, unlike spirometry.
- Clinical severity scores like PRAM may be more responsive to acute changes in asthma severity than spirometry in pediatric patients.
Objectives:
To examine the time-dependent changes of spirometry (percent-predicted forced expiratory volume in 1 second [%FEV(1)]) and the Pediatric Respiratory Assessment Measure (PRAM) during the treatment of acute asthma exacerbations.
Study Design:
We conducted a prospective study of participants aged 5-17 years with acute asthma exacerbations managed in a Pediatric Emergency Department. %FEV(1) and the PRAM were recorded pretreatment and at 2 and 4 hours. We examined responses at 2 and 4 hours following treatment and assessed whether the changes of %FEV(1) and of the PRAM differed during the first and the second 2-hour treatment periods.
Results:
Among 503 participants, median [interquartile range, IQR] age was 8.8 [6.9, 11.4], 61% were male, and 63% were African-American. There was significant mean change of %FEV(1) during the first (+15.4%; 95% CI 13.7 to 17.1; p < .0001), but not during the second (+1.5%; 95% CI -0.8 to 3.8; p = .21), 2-hour period and of the PRAM during the first (-2.1 points; 95% CI -2.3 to -1.9; p < .0001) and the second (-1.0 point; 95% CI -1.3 to -0.7; p < .0001) 2-hour periods.
Conclusions:
Most improvement of lung function and clinical severity occur in the first 2 hours of treatment. Among pediatric patients with acute asthma exacerbations, the PRAM detects significant and clinically meaningful change of severity during the second 2-hour treatment, whereas spirometry does not. This suggests that spirometry and clinical severity scores do not have similar trajectories and that clinical severity scores may be more sensitive to clinical change of acute asthma severity than spirometry.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration can...
COPD: Management Using Bronchodilators and Corticosteroids
